ABREVA
-
docosanol cream
GlaxoSmithKline Consumer Healtcare LP
----------
Drug FactsDocosanol 10%
Cold sore/fever blister treatment
For external use only
If swallowed, get medical help or contact a poison control center right away.
benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate
call toll-free 1-877-709-3539 (English/Spanish) weekdays
visit us at www.abreva.com
If you are not completely satisfied, save receipt and remaining product, and call us at 1-877-709-3539 weekdays.
Abreva and logo design and overall design elements are trademarks owned by GlaxoSmithKline.
Distributed for Avanir Pharmaceuticals by
GlaxoSmithKline Consumer Healthcare, L.P.
Moon Twp, PA 15108
Made in Germany
© 2008 GlaxoSmithKline. 27675PA
How is ABREVA different from the over-the-counter cold sore remedies I have already been using?
Abreva is the only FDA approved non-prescription cold sore medicine that can actually shorten healing time and the duration of symptoms. The sooner you start using ABREVA, the sooner you can begin healing your cold sore.
Who can use ABREVA?
Adults and children 12 years and over can use ABREVA.
How often can I apply ABREVA?
ABREVA should be used five times a day until the cold sore is healed. Apply it directly to the cold sore at the first sign of a tingle, redness, bump or itch for best results.
Can I apply cosmetics on top of ABREVA?
Yes, cosmetics such as lipstick may be applied over ABREVA. However, use a separate applicator, like a cotton swab, to apply cosmetics over an unhealed cold sore to avoid spreading the infection. For best results, remove any cosmetics prior to applying ABREVA.
abreva®
DOCOSANOL 10% CREAM
Cold Sore/Fever Blister Treatment
Only FDA Approved to Shorten Healing Time*
Cold Sore Treatment
PHARMACIST RECOMMENDED #1
NET WT
2g (.07 oz)
ABREVA
docosanol cream |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA020941 | 03/19/2010 |
Labeler - GlaxoSmithKline Consumer Healtcare LP (091328625) |